Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Sim Yap

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Journal of Breast Cancer|April 12, 2016
Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideJungsil Ro, Fiona Tsui-Fen Cheng, Virote Sriuranpong, et al.
Journal of Breast Cancer|July 9, 2019
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast CancerYi Heng Seow, Ru Xin Wong, John Heng Chi Lim, et al.
Current Medical Research and Opinion|June 17, 2020
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitorsShaheenah Dawood, Joanne Wing-Yan Chiu, Chiun-Sheng Huang, et al.
Breast Cancer Research and Treatment|February 29, 2012
Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidenceYi Ling Teo, Manit Saetaew, Suthan Chanthawong, et al.
Oncotarget|July 16, 2014
The NF1 gene revisited - from bench to bedsideYoon-Sim Yap, John R McPherson, Choon-Kiat Ong, et al.
Clinical and Translational Science|December 31, 2020
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsTomomi Hata, Kenichi Nakamura, Kan Yonemori, et al.
The Breast Journal|March 4, 2008
Time trends in the outcome of elderly patients with breast cancerSarah Hughes, Yolanda Barbachano, Sue Ashley, et al.
BMC Medicine|August 14, 2023
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trialJoanne Chiu, Fei Su, Mukta Joshi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancerHugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Breast Cancer Research and Treatment|September 17, 2011
Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patientsRaymond Ng, Chun Fan Lee, Nan Soon Wong, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Journal of Breast Cancer|April 12, 2016
Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideJungsil Ro, Fiona Tsui-Fen Cheng, Virote Sriuranpong, et al.
Journal of Breast Cancer|July 9, 2019
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast CancerYi Heng Seow, Ru Xin Wong, John Heng Chi Lim, et al.
Current Medical Research and Opinion|June 17, 2020
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitorsShaheenah Dawood, Joanne Wing-Yan Chiu, Chiun-Sheng Huang, et al.
Breast Cancer Research and Treatment|February 29, 2012
Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidenceYi Ling Teo, Manit Saetaew, Suthan Chanthawong, et al.
Oncotarget|July 16, 2014
The NF1 gene revisited - from bench to bedsideYoon-Sim Yap, John R McPherson, Choon-Kiat Ong, et al.
Clinical and Translational Science|December 31, 2020
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsTomomi Hata, Kenichi Nakamura, Kan Yonemori, et al.
The Breast Journal|March 4, 2008
Time trends in the outcome of elderly patients with breast cancerSarah Hughes, Yolanda Barbachano, Sue Ashley, et al.
BMC Medicine|August 14, 2023
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trialJoanne Chiu, Fei Su, Mukta Joshi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancerHugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Breast Cancer Research and Treatment|September 17, 2011
Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patientsRaymond Ng, Chun Fan Lee, Nan Soon Wong, et al.
Pageof 10